Gene: UBE4B
Official Full Name: ubiquitination factor E4Bprovided by HGNC
Gene Summary: The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes an additional conjugation factor, E4, which is involved in multiubiquitin chain assembly. This gene is also the strongest candidate in the neuroblastoma tumor suppressor genes. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32027 | UBE4B Knockout cell line (HeLa) | Human | UBE4B | 1:3~1:6 | Negative | Online Inquiry |
KO32028 | UBE4B Knockout cell line (HCT 116) | Human | UBE4B | 1:2~1:4 | Negative | Online Inquiry |
KO32029 | UBE4B Knockout cell line (HEK293) | Human | UBE4B | 1:3~1:6 | Negative | Online Inquiry |
KO32030 | UBE4B Knockout cell line (A549) | Human | UBE4B | 1:3~1:4 | Negative | Online Inquiry |
UBE4B Gene Knockout Cell Lines are genetically modified cell lines designed to lack the UBE4B gene, which plays a crucial role in the ubiquitin-proteasome pathway. This pathway is essential for protein degradation, cell cycle regulation, and the maintenance of protein homeostasis, making UBE4B a significant target for studying various cellular processes and pathological conditions.
The primary function of UBE4B involves mediating polyubiquitination, which tags proteins for degradation by the proteasome. Through the absence of this gene, researchers can investigate the consequences of disrupted ubiquitin signaling on cellular functions, such as apoptosis, cell cycle progression, and response to stress. The knockout model allows for a clearer understanding of the UBE4B-mediated regulatory mechanisms and their implications in diseases, particularly in cancer and neurodegenerative disorders.
In research settings, UBE4B Gene Knockout Cell Lines can be invaluable for dissecting the molecular pathways impacted by ubiquitination. This has significant implications for drug discovery, as targeting the ubiquitin-proteasome system is an innovative therapeutic approach for diseases where protein accumulation is implicated. Furthermore, these cell lines provide an excellent platform for the validation of potential clinical interventions focused on restoring normal cellular homeostasis.
What sets UBE4B Gene Knockout Cell Lines apart from other knockout models is their highly specific targeting and well-validated genetic modification, ensuring reliable and reproducible results. They are particularly advantageous for laboratories aiming to investigate UBE4B-related mechanisms without the confounding effects present in wild-type cell lines.
For researchers and clinicians, these specialized cell lines represent a pivotal resource in advancing our understanding of cellular regulation and in identifying new therapeutic strategies. Partnering with us means you gain access to meticulously characterized models backed by robust expertise in genetic engineering. Our commitment to quality ensures that you receive not only advanced biological tools but also exceptional support for your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.